JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...

We recently published a list of 10 Must-Watch AI Stocks Dominating Headlines. In this article, we are going to take a look at ...

In the sometimes-formulaic world of securities class action litigation, there’s a buzzy new reason for shareholders to sue: "AI washing." ...

Key issues to consider before entering into a settlement with a securities regulator, including the scope of the regulators’ ...

In a report released today, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi (SNY – Research Report). The ...